Associate Chief, Hematology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Hematology
Dr. Ellis J. Neufeld, MD
|
|
Give Review
Doctor Ellis J. Neufeld, MD is an expert in the field of Hematology. He attended Washington University School of Medicine in St. Louis. He has 5 awards "William Hathaway Visiting Professor", "Abelson Visiting Professor", "Coopersmith Visiting Professor", "National President's Award" and "Elected Member". Doctor Ellis J. Neufeld, MD is also published. He has 95 publications published. The lastest publication: "Center-Based Quality Initiative Targets Youth Preparedness for Medical Independence: HEMO-Milestones Tool in a Comprehensive Hemophilia Clinic Setting.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Center-Based Quality Initiative Targets Youth Preparedness for Medical Independence: HEMO-Milestones Tool in a Comprehensive Hemophilia Clinic Setting.
- Erythrocyte pyruvate kinase deficiency: 2015 status report.
- Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.
- Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.
- Sports participation in children and adolescents with immune thrombocytopenia (ITP).
- Safety update on the use of recombinant activated factor VII in approved indications.
- Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results.
- Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.
- Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system.
- Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre-based pharmacy hit the mark?
- Treatment and outcomes of immune cytopenias following solid organ transplant in children.
- Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Obs...
- MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.
- Rituximab for treatment of inhibitors in haemophilia A. A Phase II Study.
- Relationship among chelator adherence, change in chelators, and quality of life in Thalassemia.
- The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience.
- R2 and R2* are equally effective in evaluating chronic response to iron chelation.
- Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240...
- Novel dominant β-thalassemia: Hb Boston-Kuwait [codon 139/140(+T)].
- Pregnancy outcomes in women with thalassemia in North America and the United Kingdom.
- Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention.
- Induced pluripotent stem cells with a mitochondrial DNA deletion.
- Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).
- Human T Cell Lymphotropic Virus Type 1 Infection Among U.S. Thalassemia Patients.
- Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (...
- Increased leucocyte apoptosis in transfused ?-thalassaemia patients.
- Effect of acute bleeding on daily quality of life assessments in patients with congenital hemophilia with inhibitors and their families: observations from the dosing o...
- Inadequate dietary intake in patients with thalassemia.
- Trends in anti-D immune globulin for childhood immune thrombocytopenia: Usage, response rates, and adverse effects.
- Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population.
- Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.
- Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: Risk factors and hospital variation.
- Risks factors and mortality associated with an elevated tricuspid-regurgitant-jet-velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical ...
- Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation.
- Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers.
- Iron chelation adherence to deferoxamine and deferasirox in thalassemia.
- A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload.
- Renal dysfunction in patients with thalassaemia.
- Red cell alloimmunization in a diverse population of transfused patients with thalassaemia.
- Hormonal contraception and thrombotic risk: a multidisciplinary approach.
- The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Insti...
- Clinical Impact of an Anticoagulation Screening Service at a Pediatric Tertiary Care Facility
- Update on iron chelators in thalassemia.
- Observational cohort study of pediatric inpatients with central venous catheters at 'intermediate risk' of thrombosis and eligible for anticoagulant prophylaxis.
- Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort.
- Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies.
- Education and employment status of children and adults with thalassemia in North America.
- Preface to Cooley's Anemia: Ninth Symposium.
- Genetic studies in pediatric ITP: outlook, feasibility, and requirements.
- Infantile myofibroma or lymphatic malformation: differential diagnosis of neonatal cystic cervicofacial lesions.
- Pain as an emergent issue in thalassemia.
- Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission.
- Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations.
- Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.
- Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter.
- Deferasirox pharmacokinetics in patients with adequate versus inadequate response.
- Remission from transfusion-dependence in a patient with congenital dyserythropoietic anemia (CDA) and increased intensity of iron chelation.
- Compliance with immunizations in splenectomized individuals with hereditary spherocytosis.
- Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion.
- One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
- Response to mercaptopurine for refractory autoimmune cytopenias in children.
- Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.
- Female monozygotic twins discordant for hemophilia A due to nonrandom X-chromosome inactivation.
- Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias.
- Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia.
- The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
- Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL6...
- Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
- Evaluation of the coagulation system in children with two-ventricle congenital heart disease.
- Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools.
- X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
- Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
- Treatment with rituximab in benign and malignant hematologic disorders in children.
- Urinary hepcidin in congenital chronic anemias.
- Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
- Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?
- Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions.
- Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.
- Screening and counseling for thalassemia.
- Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.
- Hemoglobin Jamaica plain--a sickling hemoglobin with reduced oxygen affinity.
- Complications of beta-thalassemia major in North America.
- Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr).
- Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA).
- Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.
- Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A.
- Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.
- Time course of early induction of intracellular adhesion molecule-1 messenger RNA during reperfusion, following cardiopulmonary bypass with hypothermic circulatory arr...
- Chronic disseminated intravascular coagulation and childhood-onset skin necrosis resulting from homozygosity for a protein C Gla domain mutation, Arg15Trp.
- Prospective reevaluation of the association between thrombotic diathesis and legg-perthes disease.
- Risk factors for thromboembolism in teens: when should I test?
- Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure.
- Genetic ablation of the CDP/Cux protein C terminus results in hair cycle defects and reduced male fertility.
- Myocardial immediate early gene activation after cardiopulmonary bypass with cardiac ischemia-reperfusion.
Schools
Washington University In St Louis School Of Medicine
Children39s Hospital Boston
Wesleyan University
Doctors Specialties
- Clinical Genetics
- Pediatrics
- Hematology
Accepted Insurances
Awards
- William Hathaway Visiting Professor
- Abelson Visiting Professor
- Coopersmith Visiting Professor
- National President's Award
- Elected Member
Education
-
Boston Children's Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1215928544 | |
| NPPES Provider LastName | NEUFELD | |
| NPPES Provider FirstName | ELLIS | |
| NPPES Provider ZIPCode | 021155724 | |
| NPPES Provider State | MA | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 16.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215928544 |
| Last Name Of The Provider | NEUFELD |
| First Name Of The Provider | ELLIS |
| View All |
Similar Doctors
|
|
Dr. Audrey C. Woerner, MD |
|
|
Dr. David R. D'Adamo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jens G. Lohr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth A. Bauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beth A. Overmoyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alyssa Kennedy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Israel Green-Hopkins, MD |
|
|
Dr. Amy E. Levenson, MD |
|
|
Dr. George P. Atkinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John P. Johnson, MD |
|
|
Dr. Theresa A. Willett, MD |